These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33912499)

  • 21. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses.
    Shereen MA; Khan S; Kazmi A; Bashir N; Siddique R
    J Adv Res; 2020 Jul; 24():91-98. PubMed ID: 32257431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives.
    Kotta S; Aldawsari HM; Badr-Eldin SM; Alhakamy NA; Md S; Nair AB; Deb PK
    Front Mol Biosci; 2020; 7():606393. PubMed ID: 33282914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current therapeutic options for coronavirus disease 2019 (COVID-19)-lessons learned from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) therapy: a systematic review protocol.
    Zhang ZL; Zhong H; Liu YX; Le KJ; Cui M; Yu YT; Gu ZC; Gao Y; Lin HW
    Ann Transl Med; 2020 Nov; 8(22):1527. PubMed ID: 33313272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
    Wang Y; Zhou F; Zhang D; Zhao J; Du R; Hu Y; Cheng Z; Gao L; Jin Y; Luo G; Fu S; Lu Q; Du G; Wang K; Lu Y; Fan G; Zhang Y; Liu Y; Ruan S; Liu W; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
    Trials; 2020 May; 21(1):422. PubMed ID: 32448345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial.
    Desilles JP; Gregoire C; Le Cossec C; Lambert J; Mophawe O; Losser MR; Lambiotte F; Le Tacon S; Cantier M; Engrand N; Trouiller P; Pottecher J
    Trials; 2020 Jun; 21(1):548. PubMed ID: 32560746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and Development of Therapeutics for COVID-19.
    Rando HM; Wellhausen N; Ghosh S; Lee AJ; Dattoli AA; Hu F; Byrd JB; Rafizadeh DN; Lordan R; Qi Y; Sun Y; Brueffer C; Field JM; Ben Guebila M; Jadavji NM; Skelly AN; Ramsundar B; Wang J; Goel RR; Park Y; ; Boca SM; Gitter A; Greene CS
    mSystems; 2021 Dec; 6(6):e0023321. PubMed ID: 34726496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and immunogenicity of the COVID-19 mRNA vaccine CS-2034: A randomized, double-blind, dose-exploration, placebo-controlled multicenter Phase I clinical trial in healthy Chinese adults.
    Jin Z; Wu J; Wang Y; Huang T; Zhao K; Liu J; Wang H; Zhu T; Gou J; Huang H; Wu X; Yin H; Song J; Li R; Zhang J; Li L; Chen J; Li X; Zhang M; Li J; Hou M; Song Y; Wang B; Gao Q; Wu L; Kong Y; Dong R
    J Infect; 2023 Dec; 87(6):556-570. PubMed ID: 37898410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial.
    Zhang C; Li J; Wu Z; Wang H; Que C; Zhao H; Wang G
    Trials; 2020 Jun; 21(1):495. PubMed ID: 32513299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pipeline Pharmacological Therapies in Clinical Trial for COVID-19 Pandemic: a Recent Update.
    Kumari P; Rawat K; Saha L
    Curr Pharmacol Rep; 2020; 6(5):228-240. PubMed ID: 32837854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical research during the COVID-19 pandemic.
    AlNaamani K; AlSinani S; Barkun AN
    World J Clin Cases; 2020 Aug; 8(15):3156-3163. PubMed ID: 32874970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials.
    Arab-Zozani M; Hassanipour S; Ghoddoosi-Nejad D
    BMJ Open; 2020 Jul; 10(7):e039730. PubMed ID: 32737100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronavirus Disease: A Review of a New Threat to Public Health.
    Ramphul K; Mejias SG
    Cureus; 2020 Mar; 12(3):e7276. PubMed ID: 32300496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2/COVID-19: a primer for cardiologists.
    de Vries AAF
    Neth Heart J; 2020 Jul; 28(7-8):366-383. PubMed ID: 32671650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial.
    Abayomi A; Osibogun A; Ezechi O; Wright K; Ola B; Ojo O; Kuyinu Y; Zamba E; Abdur-Razzaq H; Erinoso OA; Anya SE
    Trials; 2021 Dec; 22(1):869. PubMed ID: 34863267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review and meta-analysis protocol examining the clinical characteristics and epidemiological features of olfactory dysfunction (OD) in coronavirus disease 2019 (COVID-19).
    Tan RQ; Li WTV; Shum WZ; Chu SC; Li HL; Shea YF; Chung TW
    Syst Rev; 2021 Mar; 10(1):73. PubMed ID: 33691796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.